Skip to main content
. 2019 Jul 9;14:59–65. doi: 10.1515/med-2019-0009

Figure 2.

Figure 2

miR-107 inhibits the proliferation of breast cancer

Cell proliferation of the group treated with Taxol+miR-107 mimics is considerably lower than that of the cells in Taxol alone. Therefore, miR-107 expression can increase the drug sensitivity of breast cancer cells in vitro. Data are presented as means ± SD of three independent experiments. *, p < 0.05, **, p < 0.01.